보고서 요약(국문)

시장 개요
전 세계 혈관성형술용 풍선 시장은 2022년 22억 달러 규모에 도달했으며, 2030년까지 29억 달러 규모로 성장할 것으로 예상됩니다. 전 세계 혈관성형술용 풍선 시장은 예측 기간(2023~2030년) 동안 연평균 3.5%의 성장률을 보일 것으로 전망됩니다.
혈관성형술용 풍선은 주로 관상동맥 질환(CAD) 치료에 사용됩니다. CAD는 동맥 내에 플라크가 축적되어 동맥이 좁아지거나 막히는 질환입니다. 풍선을 이용한 혈관성형술은 피부에 작은 절개를 통해 시행하는 최소 침습 시술로, 주로 사타구니나 손목 부위에 시행됩니다.
생활 습관 관련 질환의 증가와 최소 침습 시술에 대한 수요 증가 등이 시장 성장을 견인할 것으로 예상됩니다. 또한, 특히 선진국에서 약물 방출 풍선 및 절단 풍선과 같은 혈관성형술 분야의 첨단 기술 도입이 빠르게 진행됨에 따라 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.

시장 동향
기업 전략 및 연구 개발에 대한 집중도 증가가 시장 성장을 촉진할 것입니다.
기업 전략 및 연구 개발에 대한 집중도 증가는 시장 성장을 견인할 것입니다. 예를 들어, 2021년 6월 17일, Sectoral Asset Management는 독자적인 톱니형 기술을 사용하는 차세대 혈관성형술 풍선 제조업체인 Cagent Vascular Inc.에 900만 달러를 투자했습니다. 투자와 더불어 Marc-Andre Marcotte가 이사회에 합류했습니다. 이 자금은 무릎 아래(BTK)용 Serranator 제품의 상용화 및 규모 확대를 가속화하는 데 사용될 예정입니다.

또한, 2022년 4월 22일, Accumed Radial Systems는 혁신적이고 독자적인 획기적인 Accumed Radial 혈관내 확장(ARIVE) 기술의 프로토타입 개발을 위해 POBA Medical, Inc.와 전략적 계약을 체결했다고 발표했습니다. POBA는 Accumed Radial 팀과 협력하여 다양한 응용 분야에 적용 가능한 ARIVE 프로토타입을 제작하고, 설계, 제조 및 규모 확장에 대한 전문 지식을 제공할 예정입니다. POBA는 동시에 Accumed Radial에 투자할 것입니다. 이러한 요인들은 예측 기간 동안 시장 확대를 촉진할 것으로 예상됩니다.
관상동맥 및 말초동맥 질환 발생률 증가로 시장 성장 촉진
말초동맥 및 관상동맥 질환은 죽상경화증의 흔한 증상이며 뇌졸중, 심근경색 및/또는 심혈관 질환으로 인한 사망으로 이어질 수 있습니다. 이러한 질환의 유병률 증가는 향후 몇 년 동안 시장 확대를 견인할 것으로 예상됩니다. 미국 질병통제예방센터(CDC)에 따르면, 관상동맥질환은 가장 흔한 심장 질환으로, 2021년까지 약 37만 5천 명의 사망자를 발생시켰습니다. 20세 이상 인구 20명 중 약 1명꼴로 관상동맥질환을 앓고 있습니다.
2021년에는 관상동맥질환으로 인한 사망자의 거의 20%가 65세 미만에서 발생했습니다. 결과적으로 관상동맥질환은 증가 추세에 있으며, 이는 시장 성장에 기여하고 있습니다.
하지만 높은 비용과 혈관성형술과 관련된 수술 후 합병증은 시장 성장을 저해할 가능성이 있습니다.
혈관성형술과 관련된 높은 비용과 수술 후 어려움은 시장 확대를 저해할 것으로 예상됩니다. 미국 국립 의학 도서관에 따르면 외래 환자 진료비를 포함한 시술당 평균 총 비용은 21,893달러였으며, 혈관성형술 후 6~10시간 이내에 재협착, 심근경색, 심실세동, 심근경색, 스텐트 위치 이상, 동맥류, 신부전, 발작과 같은 합병증이 발생했습니다. 이러한 요소들은 시장 성장을 저해할 가능성이 높습니다.
코로나19 영향 분석
2020년 9월에 발표된 한 연구에 따르면, 현재의 코로나19 팬데믹 상황에서 심장 수술을 받는 것은 코로나19로 인해 합병증 위험이 높아진 심장 환자와 이들을 돌보는 의료진 모두에게 복합적인 위험을 초래합니다. 또한, 미국 외과 학회와 미국 마취과 학회는 코로나19 검사 결과 후 최소 14일 동안 선택적 심장 수술을 연기할 것을 권고했습니다.

코로나19 관련 여러 요인으로 인해 선택적 혈관성형술 수술이 중단될 것으로 예상되며, 이는 혈관성형술용 풍선 사용에 영향을 미칠 것입니다. 이 기간 동안 시장은 미미한 성장 또는 전혀 성장을 경험하지 못할 것으로 예상됩니다.
러시아-우크라이나 전쟁 영향 분석
러시아-우크라이나 전쟁은 해당 지역의 주요 시장 참여 기업의 존재 및 발생률이 낮기 때문에 전 세계 혈관성형술용 풍선 시장에 미치는 영향은 미미할 것으로 예상됩니다. 그러나 원자재, 검사 제품 및 장비의 수출입은 예측 기간 동안 전 세계 혈관성형술용 풍선 시장에 약간의 영향을 미칠 것으로 예상됩니다.
인공지능(AI) 영향 분석
인공지능은 전 세계 혈관성형술용 풍선 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. AI 알고리즘은 혈관조영술이나 컴퓨터 단층 혈관조영술(CTA) 스캔과 같은 의료 영상을 분석하여 혈관 내 병변이나 막힘을 식별하고 위치를 파악하는 데 도움을 줄 수 있기 때문입니다.

이 분석은 혈관 막힘의 크기, 위치 및 심각도에 대한 정보를 제공하여 중재 심장 전문의가 혈관 성형술 시술을 계획하는 데 도움을 줍니다. 인공지능(AI)은 혈관 성형 풍선 시술을 지원하는 데 큰 잠재력을 보여주지만, 의료 전문가의 전문 지식과 판단을 대체하는 것이 아니라 지원하는 도구로 사용해야 한다는 점에 유의해야 합니다.
세분화 분석
전 세계 혈관 성형 풍선 시장은 제품 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
병원 부문은 예측 기간 동안 혈관 성형 풍선 시장 점유율의 약 34.5%를 차지할 것으로 예상됩니다.
병원 부문은 예측 기간 동안 전체 혈관 성형 풍선 시장의 약 34.5%를 차지할 것으로 예상됩니다. 동맥경화 및 심부전을 포함한 생활 습관 질환을 앓고 있는 고령 인구의 상당한 증가는 환자 수를 늘리고 병원 수익을 증가시킬 것으로 예측됩니다. 또한, 기존 수술 방식과 비교했을 때 최소 침습 수술은 수술 시 불편함, 부상, 흉터, 입원 기간 단축, 높은 정확도, 빠른 회복 시간 등 여러 가지 이점을 제공하여 더 많은 환자들이 최소 침습 풍선 혈관성형술을 선택하도록 유도합니다.
예를 들어, 미국 심장학회(American College of Cardiology)에 따르면 2020년 미국에서는 연간 약 210만 건의 혈관성형술이 시행되었습니다. 또한, 병원은 전문 클리닉에 비해 접근성과 경제성이 높아 더 많은 환자를 유치할 것으로 예상됩니다. 이러한 모든 요인들이 시장 성장에 영향을 미칠 것으로 전망됩니다.
지역 분석
북미 지역은 예측 기간 동안 전 세계 혈관성형 풍선 시장에서 가장 큰 비중을 차지할 것으로 예상됩니다.
북미 지역은 예측 기간 동안 전 세계 혈관성형 풍선 시장에서 약 40.1%의 가장 큰 비중을 차지할 것으로 예상됩니다. 북미는 혈관성형 풍선 시장에서 가장 높은 매출 점유율을 기록했습니다. 주요 업계 플레이어들의 존재, 증가하는 의료비 지출, 그리고 미국 규제 기관의 제품 승인 증가가 시장 성장을 견인할 것으로 예상됩니다.
예를 들어, 2023년 1월 2일 필립스 영상 유도 치료 회사(Philips Image Guided Therapy Corp.)의 스텔라렉스 0.035 OTW 약물 코팅 혈관 성형 풍선(Stellarex 0.035 OTW Drug-coated Angioplasty Balloon)이 미국 식품의약국(FDA)의 승인을 받았습니다. 스텔라렉스 0.035 OTW 약물 코팅 혈관 성형 풍선(Stellarex 035 DCB)은 말초 동맥 질환(PAD)으로 인해 막히거나 좁아진 허벅지와 무릎의 동맥을 다시 열어줍니다. 이러한 발전은 해당 지역 시장의 강력한 제품 포트폴리오를 더욱 강화할 것으로 전망됩니다.

경쟁 환경
시장의 주요 글로벌 업체로는 Boston Scientific Corporation, BIOTRONIK, Medtronic Plc, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, BD, INFINITY Angioplasty Balloon, Koninklijke Philips N.V 등이 있습니다.
보고서 구매 이유

• 제품 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 혈관성형 풍선 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.

• 모든 세그먼트를 포함한 혈관성형 풍선 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품 정보를 담은 Excel 파일 형태의 제품 맵핑을 제공합니다.

글로벌 혈관성형술용 풍선 시장 보고서는 약 53개의 표, 54개의 그림, 그리고 195페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Angioplasty Balloons Market reached US$ 2.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.9 billion by 2030. The global angioplasty balloons market market is expected to exhibit a CAGR of 3.5% during the forecast period (2023-2030).
Angioplasty balloons are primarily used in the treatment of coronary artery disease (CAD), which occurs due to the buildup of plaque within the arteries, leading to their narrowing or blockage. Angioplasty with balloons is a minimally invasive procedure that can be performed through a small incision in the skin, often in the groin or wrist area.
Factors such as the increased occurrence of lifestyle-related disorders and the increasing demand for minimally invasive procedures are anticipated to propel the market. Moreover, the Rapid adoption of advanced technologies, particularly in the developed world, in the angioplasty segment, including such drug-eluting and cutting balloons, is estimated to drive market growth throughout the forecast period.
Market Dynamics
The Increased Focus on Companies Strategies and R&D will Drive the Market Growth
The increased focus on companies strategies and R&D will drive the market growth. For instance, on June 17, 2021, Sectoral Asset Management has made a $9 million investment in Cagent Vascular Inc., a producer of next generation angioplasty balloons using unique serration technology. Marc-Andre Marcotte has joined the board of directors in addition to the investment. The funds will be used to expedite the commercialization and scaling of the Serranator below-the-knee (BTK) product.
Additionally, on April 22, 2022, Accumed Radial Systems announce a strategic agreement with POBA Medical, Inc. to create prototypes of our innovative, proprietary, and game-changing Accumed Radial Intra Vascular Extension (ARIVE) technology. POBA will collaborate with Accumed Radial teams to build ARIVE prototypes for multiple applications, while providing design, manufacturing, and scale-up expertise. POBA will invest in Accumed Radial at the same time. The aforementioned factors are projected to fuel market expansion over the forecast period.
Increasing Incidence of Coronary and Periphery Artery Diseases is Likely to Boost the Market Growth
Peripheral and coronary artery disease are frequent symptoms of atherosclerosis and can lead to stroke, myocardial infarction, and/or death from cardiovascular disease. The rising prevalence of these disorders is expected to drive market expansion in the following years. According to the CDC, coronary heart disease is the most frequent type of heart disease, killing around 375,000 individuals by 2021. CAD affects about one in every twenty persons aged 20 and over.
In 2021, almost 2 out of every 10 deaths from CAD will occur in persons under the age of 65. As a result, coronary heart disease is on the rise, contributing to market growth.
High Costs And the Post-Operational Complications Associated with Angioplasty are Likely to Hamper the Market Growth
High costs and post-operative difficulties associated with angioplasty are expected to stifle market expansion. According to the National Library of Medicine, the average total charge per procedure, including outpatient charges, was $21,893, and complications such as restenosis, heart attack, ventricular fibrillation, myocardial infarction, misplacement of a stent, aneurysms, kidney failure, and seizures occurred within 6 to 10 hours of angioplasty. These elements are likely to hinder market growth.
COVID-19 Impact Analysis
According to a study released in September 2020, cardiac surgery during the present COVID-19 pandemic poses a combined danger for both cardiac patients, who are now at a higher risk of complications due to COVID-19, and the healthcare staff who care for these patients. Furthermore, the American College of Surgeons and the American Society of Anesthesiologists recommended postponing elective heart surgery for at least 14 days following a COVID-19 test result.
As a result of the various considerations surrounding COVID-19, elective angioplasty surgeries are projected to be suspended, affecting the use of angioplasty balloons. During this period, the market may experience little, if any are present, growth.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine is estimated to have a minimal impact on the global angioplasty balloons market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global angioplasty balloons market in the forecast period.
Artificial Intelligence Impact Analysis
Artificial intelligence is anticipated to impact the global angioplasty balloons market positively . Due to AI algorithms can analyze medical images, such as angiograms or computed tomography angiography (CTA) scans, to assist in the identification and localization of lesions or blockages within the blood vessels.
This analysis helps the interventional cardiologist in planning the angioplasty procedure by providing insights into the size, location, and severity of the blockage. It's important to note that while AI shows great potential in assisting with angioplasty balloon procedures, it should always be used as a tool to support healthcare professionals rather than a replacement for their expertise and judgment.
Segment Analysis
The global angioplasty balloons market is segmented based on product type, application, end user, and region.
The Hospital Segment is Estimated to Hold around 34.5% of the Angioplasty Balloons Market Share During the Forecast Period
The hospital segment holds about 34.5% of the total angioplasty balloons market in the forecast period. The significant increase in the older population suffering from lifestyle disorders including atherosclerosis and heart failure is predicted to increase the patient pool and boost hospital income production. Furthermore, as compared to traditional operations, the numerous benefits of minimally invasive surgeries, such as reduced surgical discomfort, injury, scarring, hospital stay, higher accuracy, and faster recovery time, motivate more patients to choose minimally invasive balloon angioplasty surgeries.
For instance, according to the American College of Cardiology, roughly 2.1 million angioplasties are performed in the United States per year in 2020. Furthermore, hospitals are likely to attract a big patient base due to their greater accessibility and affordability when compared to speciality clinics. All of these factors are projected to have an impact on segment growth.
Geographical Analysis
North America is Estimated to Hold the Largest Share of the Global Angioplasty Balloons Market During the Forecast Period
The North America region holds the largest share of the global angioplasty balloons market accounting for approximately 40.1% in the forecast period. North America accounted for the maximum revenue share in the angioplasty balloons market. The presence of key industry players, the rising healthcare expenditure, and the increasing product approvals by regulatory bodies in the United States are expected to drive the market’s growth.
For instance, on January 2, 2023, the Stellarex 0.035 OTW Drug-coated Angioplasty Balloon from Philips Image Guided Therapy Corp. has been approved by the US Food and Drug Administration (FDA). Stellarex 0.035 OTW Drug-coated angioplasty balloon (Stellarex 035 DCB) reopens blocked or restricted arteries in the thigh and knee caused by peripheral arterial disease (PAD). These advancements are projected to strengthen the region's market's robust product portfolio.
Competitive Landscape
The major global players in the market include Boston Scientific Corporation, BIOTRONIK, Medtronic Plc, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, BD, INFINITY Angioplasty Balloon, and Koninklijke Philips N.V, among others.
Why Purchase the Report?
• To visualize the global angioplasty balloons market segmentation based on product type, application, end user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of angioplasty balloons market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global angioplasty balloons market report would provide approximately 53 tables, 54 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing incidence of coronary and periphery artery diseases
4.1.1.2. The increased focus on companies strategies and R&D
4.1.2. Restraints
4.1.2.1. High costs and the post-operational complications associated with angioplasty
4.1.3. Opportunity
4.1.3.1. Preference for minimally invasive procedures
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario before COVID-19
6.1.2. Scenario during COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Product Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
9.1.2. Market Attractiveness Index, By Product type
9.2. Drug Eluting Balloons
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Normal Balloons
9.4. Cutting/Scoring Balloons
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Coronary Angioplasty
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Peripheral Angioplasty
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Surgical Centers
11.4. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.6.1. The U.S.
12.2.6.2. Canada
12.2.6.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.6.1. Germany
12.3.6.2. The U.K.
12.3.6.3. France
12.3.6.4. Italy
12.3.6.5. Spain
12.3.6.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.6.1. Brazil
12.4.6.2. Argentina
12.4.6.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.6.1. China
12.5.6.2. India
12.5.6.3. Japan
12.5.6.4. Australia
12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Boston Scientific Corporation
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. BIOTRONIK
14.3. Medtronic Plc
14.4. Cordis (Cardinal Health)
14.5. Terumo Corporation
14.6. Abbott Laboratories
14.7. AngioDynamics
14.8. BD
14.9. INFINITY Angioplasty Balloon
14.10. Koninklijke Philips N.V.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

언급된 주요 기업들

Boston Scientific Corporation, 4.	Key Developments, BIOTRONIK, Medtronic Plc, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, BD, INFINITY Angioplasty Balloon, Koninklijke Philips N.V.

표 목록 (Tables)

List of Tables Table 1 Global Angioplasty Balloons Market Value, By Product Type, 2022, 2026 & 2030 (US$ Billion)

Table 2 Global Angioplasty Balloons Market Value, By Application, 2022, 2026 & 2030 (US$ Billion)

Table 3 Global Angioplasty Balloons Market Value, By End User, 2022, 2026 & 2030 (US$ Billion)

Table 4 Global Angioplasty Balloons Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 5 Global Angioplasty Balloons Market Value, By Product Type, 2022, 2026 & 2030 (US$ Billion)

Table 6 Global Angioplasty Balloons Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 7 Global Angioplasty Balloons Market Value, By Application, 2022, 2026 & 2030 (US$ Billion)

Table 8 Global Angioplasty Balloons Market Value, By Application, 2021-2030 (US$ Billion)

Table 9 Global Angioplasty Balloons Market Value, By End User, 2022, 2026 & 2030 (US$ Billion)

Table 10 Global Angioplasty Balloons Market Value, By End User, 2021-2030 (US$ Billion)

Table 11 Global Angioplasty Balloons Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 12 Global Angioplasty Balloons Market Value, By Region, 2021-2030 (US$ Billion)

Table 13 North America Angioplasty Balloons Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 14 North America Angioplasty Balloons Market Value, By Application, 2021-2030 (US$ Billion)

Table 15 North America Angioplasty Balloons Market Value, By End User, 2021-2030 (US$ Billion)

Table 16 North America Angioplasty Balloons Market Value, By Country, 2021-2030 (US$ Billion)

Table 17 South America Angioplasty Balloons Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 18 South America Angioplasty Balloons Market Value, By Application, 2021-2030 (US$ Billion)

Table 19 South America Angioplasty Balloons Market Value, By End User, 2021-2030 (US$ Billion)

Table 20 South America Angioplasty Balloons Market Value, By Country, 2021-2030 (US$ Billion)

Table 21 Europe Angioplasty Balloons Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 22 Europe Angioplasty Balloons Market Value, By Application, 2021-2030 (US$ Billion)

Table 23 Europe Angioplasty Balloons Market Value, By End User, 2021-2030 (US$ Billion)

Table 24 Europe Angioplasty Balloons Market Value, By Country, 2021-2030 (US$ Billion)

Table 25 Asia-Pacific Angioplasty Balloons Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 26 Asia-Pacific Angioplasty Balloons Market Value, By Application, 2021-2030 (US$ Billion)

Table 27 Asia-Pacific Angioplasty Balloons Market Value, By End User, 2021-2030 (US$ Billion)

Table 28 Asia-Pacific Angioplasty Balloons Market Value, By Country, 2021-2030 (US$ Billion)

Table 29 Middle East & Africa Angioplasty Balloons Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 30 Middle East & Africa Angioplasty Balloons Market Value, By Application, 2021-2030 (US$ Billion)

Table 31 Middle East & Africa Angioplasty Balloons Market Value, By End User, 2021-2030 (US$ Billion)

Table 32 Boston Scientific Corporation: Overview

Table 33 Boston Scientific Corporation: Product Portfolio

Table 34 Boston Scientific Corporation: Key Developments

Table 35 BIOTRONIK: Overview

Table 36 BIOTRONIK: Product Portfolio

Table 37 BIOTRONIK: Key Developments

Table 38 Medtronic Plc: Overview

Table 39 Medtronic Plc: Product Portfolio

Table 40 Medtronic Plc: Key Developments

Table 41 Cordis (Cardinal Health): Overview

Table 42 Cordis (Cardinal Health): Product Portfolio

Table 43 Cordis (Cardinal Health): Key Developments

Table 44 Terumo Corporation: Overview

Table 45 Terumo Corporation: Product Portfolio

Table 46 Terumo Corporation: Key Developments

Table 47 Abbott Laboratories: Overview

Table 48 Abbott Laboratories: Product Portfolio

Table 49 Abbott Laboratories: Key Developments

Table 50 AngioDynamics: Overview

Table 51 AngioDynamics: Product Portfolio

Table 52 AngioDynamics: Key Developments

Table 53 BD: Overview

Table 54 BD: Product Portfolio

Table 55 BD: Key Developments

Table 56 INFINITY Angioplasty Balloon: Overview

Table 57 INFINITY Angioplasty Balloon: Product Portfolio

Table 58 INFINITY Angioplasty Balloon: Key Developments

Table 59 Koninklijke Philips N.V: Overview

Table 60 Koninklijke Philips N.V: Product Portfolio

Table 61 Koninklijke Philips N.V: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 2 Global Angioplasty Balloons Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Angioplasty Balloons Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Angioplasty Balloons Market Share, By End User, 2022 & 2030 (%)

Figure 5 Global Angioplasty Balloons Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Angioplasty Balloons Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 7 Drug Eluting Balloons Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 8 Normal Balloons Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 9 Cutting/Scoring Balloons Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 10 Global Angioplasty Balloons Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 11 Coronary Angioplasty Application in Global Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 12 Peripheral Angioplasty Application in Global Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 13 Global Angioplasty Balloons Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 14 Hospitals End User in Global Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 15 Ambulatory Surgical Centers End User in Global Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 16 Others End User in Global Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 17 Global Angioplasty Balloons Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 18 North America Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 19 Asia-Pacific Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 20 Europe Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 21 South America Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 22 Middle East and Africa Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 23 North America Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 24 North America Angioplasty Balloons Market Share, By Product Type, 2022 & 2030 (%)

Figure 25 North America Angioplasty Balloons Market Share, By Application, 2022 & 2030 (%)

Figure 26 North America Angioplasty Balloons Market Share, By End User, 2022 & 2030 (%)

Figure 27 North America Angioplasty Balloons Market Share, By Country, 2022 & 2030 (%)

Figure 28 South America Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 29 South America Angioplasty Balloons Market Share, By Product Type, 2022 & 2030 (%)

Figure 30 South America Angioplasty Balloons Market Share, By Application, 2022 & 2030 (%)

Figure 31 South America Angioplasty Balloons Market Share, By End User, 2022 & 2030 (%)

Figure 32 South America Angioplasty Balloons Market Share, By Country, 2022 & 2030 (%)

Figure 33 Europe Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 34 Europe Angioplasty Balloons Market Share, By Product Type, 2022 & 2030 (%)

Figure 35 Europe Angioplasty Balloons Market Share, By Application, 2022 & 2030 (%)

Figure 36 Europe Angioplasty Balloons Market Share, By End User, 2022 & 2030 (%)

Figure 37 Europe Angioplasty Balloons Market Share, By Country, 2022 & 2030 (%)

Figure 38 Asia-Pacific Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 39 Asia-Pacific Angioplasty Balloons Market Share, By Product Type, 2022 & 2030 (%)

Figure 40 Asia-Pacific Angioplasty Balloons Market Share, By Application, 2022 & 2030 (%)

Figure 41 Asia-Pacific Angioplasty Balloons Market Share, By End User, 2022 & 2030 (%)

Figure 42 Asia-Pacific Angioplasty Balloons Market Share, By Country, 2022 & 2030 (%)

Figure 43 Middle East & Africa Angioplasty Balloons Market Value, 2021-2030 (US$ Billion)

Figure 44 Middle East & Africa Angioplasty Balloons Market Share, By Product Type, 2022 & 2030 (%)

Figure 45 Middle East & Africa Angioplasty Balloons Market Share, By Application, 2022 & 2030 (%)

Figure 46 Middle East & Africa Angioplasty Balloons Market Share, By End User, 2022 & 2030 (%)

Figure 47 Boston Scientific Corporation: Financials

Figure 48 BIOTRONIK: Financials

Figure 49 Medtronic Plc: Financials

Figure 50 Cordis (Cardinal Health): Financials

Figure 51 Terumo Corporation: Financials

Figure 52 Abbott Laboratories: Financials

Figure 53 AngioDynamics: Financials

Figure 54 BD: Financials

Figure 55 INFINITY Angioplasty Balloon: Financials

Figure 56 Koninklijke Philips N.V: Financials

글로벌 혈관성형술용 풍선 시장 – 2023-2030

Global Angioplasty Balloons Market - 2023-2030